• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

After the White House Conference on Hunger, Nutrition, and Health, the Obesity Medicine Association urges additional action be taken to address the obesity epidemic

Bioengineer by Bioengineer
October 5, 2022
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Denver, CO – The Obesity Medicine Association (OMA) responds to the Biden-⁠Harris Administration’s National Strategy on Hunger, Nutrition, and Health, which set forth important strategies for addressing the obesity crisis that now impacts over 100 million Americans. OMA applauds the White House’s commitment to improve access to healthy foods and physical activity for the millions of Americans struggling with food insecurity and diet-related diseases including obesity. However, the reality is that most American health insurers simply don’t cover obesity care services including pharmacotherapy and surgery.

Obesity Medicine Association (OMA)

Credit: OMA

Denver, CO – The Obesity Medicine Association (OMA) responds to the Biden-⁠Harris Administration’s National Strategy on Hunger, Nutrition, and Health, which set forth important strategies for addressing the obesity crisis that now impacts over 100 million Americans. OMA applauds the White House’s commitment to improve access to healthy foods and physical activity for the millions of Americans struggling with food insecurity and diet-related diseases including obesity. However, the reality is that most American health insurers simply don’t cover obesity care services including pharmacotherapy and surgery.

Today, the disease of obesity affects 42% of Americans, with women and minorities carrying a disproportionate burden of the disease. While access to healthy foods and physical activity options is a good first step, once a person has the disease of obesity, it is inadequate to stop further weight gain or to reverse the disease. Obesity causes countless downstream health consequences, including over 236 medical conditions such as diabetes and heart disease as well as 13 forms of cancer. Further, obesity shortens the lifespan by 6-8 years for those who are affected.

This is why at the OMA, in addition to teaching health care providers about evidence-based effective nutritional and physical activity interventions, we additionally focus on intensive lifestyle intervention to address the environmental influences that contribute to the obesity, including anti-obesity pharmacotherapy, and for select patients, bariatric and metabolic surgery.

Unfortunately, the current standard of care offered to people living with obesity is poor. Often the obesity is not diagnosed, and it is estimated that only 1-2% of people living with obesity receive the full spectrum of evidence-based care. This is in contrast to other chronic diseases like Type II diabetes, where over 85% of people receive recommended treatments including office visits, screening tests, and prescription medications.

The reality is that most American health insurers simply don’t cover obesity care services including pharmacotherapy and surgery, and those that do cover these therapies often have severe restrictions in place. For example, Medicare recipients are barred from using FDA-approved anti-obesity pharmacotherapy due to old and outdated language, and while Medicare will pay for intensive lifestyle intervention, it restricts these payments to the primary care provider, who isn’t typically trained to offer this intervention.

We urge the White House to take a close look at the Treat and Reduce Obesity Act (TROA). This act has broad bipartisan support and it seeks to remove barriers to the full spectrum of obesity care services as it relates to Medicare recipients. Enactment of TROA would allow Medicare plans to cover anti-obesity pharmacotherapy, and it would increase the reach of behavioral interventions by allowing registered dietitians and other health professionals with proper training to work with this important population.

People living with obesity deserve the same level of care as people living with other chronic diseases like diabetes. Simply improving food choices and access to physical activity would not be enough to treat diabetes, and similarly, is not adequate to treat the disease of obesity.

About the Obesity Medicine Association

The Obesity Medicine Association is the largest organization of physicians, nurse practitioners, physician assistants, and other healthcare providers dedicated to preventing, treating, and reversing the disease of obesity. Members of OMA believe treating obesity requires a scientific and individualized clinical approach comprised of nutrition, physical activity, behavior, and medication. When personalized, this comprehensive approach helps patients achieve their weight and health goals. Visit obesitymedicine.org to learn more.



Share12Tweet8Share2ShareShareShare2

Related Posts

Revolutionary Deep Learning Classifies Lung Nodules with Fat

September 1, 2025

New Predictive Model for Postpartum Hemorrhage in Cesarean Cases

September 1, 2025

Novel ADC Targets Fucosyl-GM1 in Lung Cancer

September 1, 2025

Ethiopia’s Electronic Health System: Status and Opportunities

September 1, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Do people and monkeys see colors the same way?

    112 shares
    Share 45 Tweet 28

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionary Deep Learning Classifies Lung Nodules with Fat

Tailored Risk Messages Show No Impact on Increasing Colorectal Cancer Screening Rates

New Predictive Model for Postpartum Hemorrhage in Cesarean Cases

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.